Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initiative To Integrate Clinical Laboratories into Public Health Testing, Funding Opportunity Number CDC-PA-HM06-605, 45568 [06-6802]

Download as PDF 45568 Federal Register / Vol. 71, No. 153 / Wednesday, August 9, 2006 / Notices 1. VB Texas, Inc., Houston, Texas; to become a bank holding company by acquiring 100 percent of the voting shares of Community State Bank, Boling, Texas. Board of Governors of the Federal Reserve System, August 3, 2006. Jennifer J. Johnson, Secretary of the Board. [FR Doc. E6–12921 Filed 8–8–06; 8:45 am] BILLING CODE 6210–01–S FEDERAL RESERVE SYSTEM jlentini on PROD1PC65 with NOTICES Notice of Proposals to Engage in Permissible Nonbanking Activities or to Acquire Companies that are Engaged in Permissible Nonbanking Activities The companies listed in this notice have given notice under section 4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and Regulation Y (12 CFR Part 225) to engage de novo, or to acquire or control voting securities or assets of a company, including the companies listed below, that engages either directly or through a subsidiary or other company, in a nonbanking activity that is listed in § 225.28 of Regulation Y (12 CFR 225.28) or that the Board has determined by Order to be closely related to banking and permissible for bank holding companies. Unless otherwise noted, these activities will be conducted throughout the United States. Each notice is available for inspection at the Federal Reserve Bank indicated. The notice also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the question whether the proposal complies with the standards of section 4 of the BHC Act. Additional information on all bank holding companies may be obtained from the National Information Center website at www.ffiec.gov/nic/. Unless otherwise noted, comments regarding the applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than August 23, 2006. A. Federal Reserve Bank of New York (Anne McEwen, Financial Specialist) 33 Liberty Street, New York, New York 10045-0001: 1. Westpac Banking Corporation, Sydney, Australia; to engage de novo through its subsidiary, Hastings Funds Management (US), Inc., New York, New York, in providing investment and financial advice, pursuant to section 225.28(b)(6) of Regulation Y. B. Federal Reserve Bank of San Francisco (Tracy Basinger, Director, Regional and Community Bank Group) VerDate Aug<31>2005 19:05 Aug 08, 2006 Jkt 208001 101 Market Street, San Francisco, California 94105-1579: 1. Belvedere Capital Fund II L.P. and Belvedere Capital Partners II LLC, both of San Francisco, California; to acquire Hometown Commercial Capital, LLC, Burlingame, California, and thereby engage in funding commercial real estate loans through established warehouse lines and subsequently securitizing pools through major Wall Street firms, pursuant to sections 225.28(b)(1) and (b)(2)(ii) of Regulation Y. Board of Governors of the Federal Reserve System, August 3, 2006. Jennifer J. Johnson, Secretary of the Board. [FR Doc. E6–12922 Filed 8–8–06; 8:45 am] BILLING CODE 6210–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initiative To Integrate Clinical Laboratories into Public Health Testing, Funding Opportunity Number CDC–PA–HM06– 605 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initiative to Integrate Clinical Laboratories into Public Health Testing, Funding Opportunity Number (FON) CDC–PA– HM06–605. Times and Dates: 8:30 a.m.–4:30 p.m., August 3, 2006 (Closed). 8:30 a.m.–4 p.m., August 4, 2006 (Closed). Place: Centers for Disease Control and Prevention, Building 19, Conference Room 256, 1600 Clifton Road, Atlanta, GA 30333, Telephone 404.498.2329. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to FON CDC–PA–HM06–605, ‘‘Initiative to Integrate Clinical PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 Laboratories into Public Health Testing.’’ Due to programmatic matters, this Federal Register Notice is being published on less than 15 calendar days notice to the public (41 CFR 102– 3.150(b)). Contact Person for More Information: Jack Rogers, Ph.D., Program Analyst, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS E–21, Atlanta, GA 30333, Telephone 404.498.2329. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: August 3, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 06–6802 Filed 8–8–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare and Medicaid Services [Document Identifier: CMS–10207] Emergency Clearance: Public Information Collection Requirements Submitted to the Office of Management and Budget (OMB) Center for Medicare and Medicaid Services, HHS. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare and Medicaid Services (CMS), Department of Health and Human Services, is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. AGENCY: E:\FR\FM\09AUN1.SGM 09AUN1

Agencies

[Federal Register Volume 71, Number 153 (Wednesday, August 9, 2006)]
[Notices]
[Page 45568]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-6802]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initiative To Integrate Clinical Laboratories 
into Public Health Testing, Funding Opportunity Number CDC-PA-HM06-605

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:
    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Initiative to Integrate Clinical 
Laboratories into Public Health Testing, Funding Opportunity Number 
(FON) CDC-PA-HM06-605.
    Times and Dates: 8:30 a.m.-4:30 p.m., August 3, 2006 (Closed).
    8:30 a.m.-4 p.m., August 4, 2006 (Closed).
    Place: Centers for Disease Control and Prevention, Building 19, 
Conference Room 256, 1600 Clifton Road, Atlanta, GA 30333, Telephone 
404.498.2329.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and 
the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to FON 
CDC-PA-HM06-605, ``Initiative to Integrate Clinical Laboratories into 
Public Health Testing.''
    Due to programmatic matters, this Federal Register Notice is being 
published on less than 15 calendar days notice to the public (41 CFR 
102-3.150(b)).
    Contact Person for More Information: Jack Rogers, Ph.D., Program 
Analyst, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE., MS E-21, Atlanta, GA 30333, Telephone 404.498.2329.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: August 3, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 06-6802 Filed 8-8-06; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.